ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 278.159K |
Day Range | - - - |
52 Wk Range | 8.200 - 18.240 |
Market Cap | $393.916M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 10.13% |
Days to Cover | 6.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ITeos Therapeutics (NASDAQ: ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and PepGen (NASDAQ:PEPG).
The latest price target for ITeos Therapeutics (NASDAQ: ITOS) was reported by JP Morgan on Tuesday, March 12, 2024. The analyst firm set a price target for 27.00 expecting ITOS to rise to within 12 months (a possible 145.68% upside). 5 analyst firms have reported ratings in the last year.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $10.99 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.